Chase AIPricingFAQs
Display currency
Loading news…

Haystack Oncology

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Baltimore, Maryland, United States Founded 2021 51-100 employees For Profit

Haystack Oncology enables precision oncology to optimize treatment strategies.

Haystack Oncology was acquired by Quest Diagnostics in 2023 for $300M.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
36

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
21

Company Info

Founded
2021
Employees
51-100
Operating status
Active
Company type
For Profit
Org types
company
Founders
4
News articles
49
HQ
Baltimore, Maryland, United States
Region
Greater Baltimore-Maryland Area, East Coast, Southern US
Exit date
Apr 27, 2023

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.2
Trend (30d)
2.2
Trend (90d)
1
Last leadership hire
Dec 1, 2022

Key People at Haystack Oncology

Chief Financial Officer
36
professional contacts at Haystack Oncology
Contact execs at Haystack Oncology

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Haystack Oncology

Loading news…

FAQs about Haystack Oncology

People who checked this page also checked these

Browse the full Acquirezy directory.
Haystack Oncology - Company Profile, Full Acquisitions List, Funding and Investments